Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2009
10/08/2009US20090252705 IL-6/IL-6R Fusion Protein
10/08/2009US20090252704 Therapies for cognition and learning enhancement
10/08/2009US20090252703 Use of alcohol co-solvents to improve pegylation reaction yields
10/08/2009US20090252672 Nasal delivery of therapeutic agents using tight junction agonists
10/08/2009CA2720380A1 Use of defensins against meningitis
10/08/2009CA2720306A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
10/08/2009CA2720301A1 Dispersinb tm, 5-fluorouracil, deoxyribonuclease i and proteinase k-based antibiofilm compositions and uses thereof
10/08/2009CA2720280A1 Compositions and method for reducing scar formation in wound healing
10/08/2009CA2720183A1 Liquid and freeze dried formulations
10/08/2009CA2720173A1 Highly bridged peptides from actinomadura namibiensis
10/08/2009CA2720141A1 Beta-turn peptidomimetic cyclic compounds for treating dry eye
10/08/2009CA2720112A1 Suture line administration technique using botulinum toxins
10/08/2009CA2719964A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof
10/08/2009CA2719505A1 Methods of diagnosing, preventing and treating bone mass diseases
10/08/2009CA2719216A1 Compositions and methods for treatment of neoplastic disease
10/08/2009CA2716010A1 Hemostatic microspheres
10/07/2009EP2107374A1 Polypeptide for diagnosis of vaccination
10/07/2009EP2107109A1 Recombinant vascular endothelial cell growth factor D (VEGF-D)
10/07/2009EP2107070A1 Rheumatoid arthritis remedy containing IL-6 antagonist as active ingredient
10/07/2009EP2107069A2 Novel insulin derivatives
10/07/2009EP2107068A1 MZB1, a novel B cell factor, and uses thereof
10/07/2009EP2106807A1 Compositions and kits for enhancing delivery of therapeutic agents to cells
10/07/2009EP2106801A1 IL-25 for use in the treatment of inflammatory diseases
10/07/2009EP2106800A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
10/07/2009EP2106794A1 Ubiquitin alone or in combination for use in the treatment of sweet itch.
10/07/2009EP2106790A1 Rapid acting drug delivery compositions
10/07/2009EP2106788A1 Liquid and freeze dried formulations
10/07/2009EP2106787A2 Biodegradable block copolymeric compositions for drug delivery
10/07/2009EP2106705A1 Use of a compound comprising a vegetable lectin, a proteolytic enzyme and a selenium compound for mucous membrane protection and relief of other symptoms experienced by cancer patients
10/07/2009EP2106443A2 Acid ceramidase and cell survival
10/07/2009EP2106407A2 Novel peptides for use in the treatment of obesity
10/07/2009EP2106406A2 Novel peptides for use in the treatment of obesity
10/07/2009EP2106405A2 Peptides for use in the treatment of obesity
10/07/2009EP2106267A2 Liquid mixing and injecting tool
10/07/2009EP2032596B1 Neuroprotective compounds and uses thereof
10/07/2009EP1617216B1 Novel method of screening
10/07/2009EP1434791B1 Specific binding agents of human angiopoietin-2
10/07/2009EP1421112B1 Novel serine protease
10/07/2009EP1392389B1 Microprojection array having a beneficial agent containing coating
10/07/2009EP1341545B1 Process for preparing a bone putty
10/07/2009EP1292347B1 Drug delivery apparatus
10/07/2009EP1235595B8 Integrin-mediated drug targeting
10/07/2009EP1191099B1 Novel polypeptide and dna thereof
10/07/2009EP1187917B1 Cd44 splice variant associated with rheumatoid arthritis
10/07/2009EP1105460B1 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof
10/07/2009EP1007077B1 Glutathione for the treatment of influenza infection
10/07/2009EP0907735B2 Modulators of tissue regeneration
10/07/2009EP0907730B1 Haemopoietin receptor and genetic sequences encoding same
10/07/2009CN101553985A A/D converter, A/D converting method, A/D converting program and control apparatus
10/07/2009CN101553501A Il-21变种 Il-21 variant
10/07/2009CN101553500A GnRH peptide derivative (gonadotropin-releasing hormone)
10/07/2009CN101553244A Treatment for intimal hyperplasia and related conditions
10/07/2009CN101553243A Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
10/07/2009CN101553242A Erythropoietin receptor peptide formulations and uses
10/07/2009CN101553127A Livestock management for improved reproductive efficiency
10/07/2009CN101550193A Novel IZ-shGITRL fusion protein and preparation method and application thereof
10/07/2009CN101550185A New tumor-related gene or protein and application thereof
10/07/2009CN101550184A Marking protein on tumor drug-resistant film surface and application thereof as drug-resistant tumor drug target protein
10/07/2009CN101550181A Human papilloma virus 16 type E7 protein functional antagonist peptide and encoding gene and application thereof
10/07/2009CN101550178A Blood polypeptide and preparation method and application thereof
10/07/2009CN101549152A Alliin/alliinase dualistic drug-releasing multilayer tablet that can resist infection diseases caused by helicobacter pylori and candida albicans and the like
10/07/2009CN101549151A Alliin/alliinase dualistic drug-releasing multilayer tablet
10/07/2009CN101549150A Application of prourokinase and prourokinase mutant in acute myocardial infarction facilitated percutaneous coronary artery intervention
10/07/2009CN101549149A New nasal spray formulation of calcitonin aqueous solution
10/07/2009CN101549148A Application of polypeptide in preparing the medicine promoting the transformation from endocardium cell to interstitial cell
10/07/2009CN101549147A Function of small RNA molecule aiming at c-Jun amino terminal kinase of human for senile dementia
10/07/2009CN101549146A Romurtide injection and preparation method thereof
10/07/2009CN101549145A Nutrient fluid capable of being radio-resistant and reducing side reaction of radiation treatment
10/07/2009CN101548961A Novel oral capsule preparation for curing diabetes mellitus and obesity
10/07/2009CN100547075C Her-2/neu DNA vaccine having anti-cancer activity
10/07/2009CN100547071C Antisense antiviral agent and method for treating ssRNA viral infection
10/07/2009CN100547000C Hornet anti-bacterial peptide, its preparing method and use
10/07/2009CN100546658C Ligand of polyoxyethylene of containing target peptide toward to liver cancer and its synthesis method
10/07/2009CN100546649C Ultrasonic microvesicle as immuno adjuvant and vaccine carrier
10/07/2009CN100546648C Transdermal botulinum toxin compositions
10/07/2009CN100546647C P185-encoding DNA and therapeutical uses thereof
10/07/2009CN100546646C Anticancer agent comprising lk8 protein as an active ingredient
10/06/2009US7598421 Lipids such as 2,3-Di-[(Z)-octadec-9-enyloxy]-propyl}-N-(2-{2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethoxy}-ethyl)-N,N-dimethylammonium bromide; integrin-binding peptides
10/06/2009US7598362 Hepatitis C virus vaccine
10/06/2009US7598356 Performed in a relatively short period of time, involves inexpensive reagents, and requires little sample preparation before and during the purification process
10/06/2009US7598355 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/06/2009US7598352 Method of identifying polypeptide monobodies which bind to target proteins and use thereof
10/06/2009US7598349 Antibodies to peptide fragments having cell death-inhibitory activity
10/06/2009US7598345 Immunostimulatory compositions and methods
10/06/2009US7598344 bi-functionally-linked biopolymer, wherein the functional linkage is between a biomaterial surface and cells or biologic molecules; takes advantage of molecular screening methods to prepare molecular structures with specific binding motifs and/or b
10/06/2009US7598343 have a maximum impurity level of Asp9-bivalirudin that does not exceed about 0.6%; anticoagulant ; batches have a pH adjusted by a base sodium hydroxide about 5-6; Hirulog-8; thrombin peptide inhibitor
10/06/2009US7598342 Alpha-fetoprotein peptides and uses thereof
10/06/2009US7598341 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
10/06/2009US7598340 Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
10/06/2009US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
10/06/2009US7598253 Reverse-turn mimetics and methods relating thereto
10/06/2009US7598235 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals
10/06/2009US7598228 Administering by direct injection into heart an expression vector comprising a nucleic acid sequence encoding AOP-1 operably linked to a promoter, wherein expression of nucleic acid sequence within cells of heart enhances production of AOP-1, protecting against myocardial cell death
10/06/2009US7598227 Modulation of apolipoprotein C-III expression
10/06/2009US7598226 Compositions and methods for the therapy and diagnosis of breast cancer
10/06/2009US7598224 Have a hydrophobic linker region and a heparin-binding region, useful as soluble biologics or as surface coatings for medical devices
10/06/2009US7598223 Methods for producing target cell reactive lymphocytes
10/06/2009US7598222 Process for solubilizing glucagon-like peptide 1 compounds
10/06/2009US7598221 Synthetic HLA binding WT-1 peptide analogues and uses thereof
10/06/2009US7598220 Hypo-oncotic aqueous solutions of molecularly dispersed chemically modified high molecular weight crosslinked hemoglobins to prepare agents for the symptomatic, primarily life-saving treatment of acute pulmonary edema; blood additive
1 ... 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 ... 3163